Medical Quality Control Reagents Supply

The contract is for the supply of stabilized latex particle solution in 10mL ampules, specifically intended for use in the quality control of blood chemistry analyzers to ensure accurate calibration and consistent performance monitoring. These reagents are critical for maintaining the precision and reliability of diagnostic equipment used in medical testing environments. The solicitation is issued as a subcontract under the NAICS code 325414, which pertains to pharmaceutical and medicine manufacturing, indicating the technical and regulated nature of the product. The offering is managed by the Department of Defense through its Medical Supply Chain FSH, underscoring the military healthcare system’s need for dependable analytical controls. All deliveries must meet exacting specifications to ensure compatibility and functionality across a range of clinical analyzers used in defense medical facilities. The response deadline for this solicitation is May 6, 2026, with the posting date set for April 29, 2026, providing a seven-day window for potential suppliers to submit proposals. The place of performance and office address details are unspecified, suggesting that the contract may involve distributed delivery to multiple military healthcare locations, likely requiring compliant packaging and logistics handling for sensitive biological materials. While no set-aside provisions are stated, the requirement is part of a broader DOD initiative to secure high-quality, reliable diagnostic reagents. The contract’s success hinges on consistent batch-to-batch stability, adherence to performance standards, and timely fulfillment to avoid disruptions in clinical testing operations.